 comparison cyclosporin d-penicillamin rheumatoid arthriti random doubl blind multicent studi ninety-two patient activ rheumatoid arthriti RA random doubl blind studi week cyclosporin initi mg/kg d-penicillamin initi mg group baselin characterist cyclosporin group patient inefficaci d-penicillamin group patient inefficaci antirheumat drug effect diseas activ signific decreas erythrocyt sediment rate d-penicillamin treatment condit trial cyclosporin altern d-penicillamin treatment patient RA